Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05703399 | Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study | active not recruiting | — | 140 | Mayo ClinicOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT07421479 | Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01)(PDO-Mercurial) | active not recruiting | — | 50 | Istituti Clinici Scientifici Maugeri SpAOTHER | 1 | Feb 19, 2026 |
| clinicaltrials |
| NCT04176848 | CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer | active not recruiting | Phase 2 | 15 | Canadian Cancer Trials GroupNETWORK | 1 | Feb 18, 2026 | clinicaltrials |
| NCT06216574 | Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial(SHINE) | active not recruiting | N/A | 340 | Wake Forest University Health SciencesOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT02157051 | Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer | active not recruiting | Phase 1 | 42 | University of WashingtonOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT05316324 | A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction | active not recruiting | Phase 3 | 353 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06756802 | Reproductive Health in Breast Cancer Survivor(ISIS) | active not recruiting | — | 22,000 | Institut Cancerologie de l'OuestOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07407244 | Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer(AKRA) | active not recruiting | N/A | 268 | Institute of Oncology LjubljanaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT02226276 | Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer | active not recruiting | N/A | 10 | City of Hope Medical CenterOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT03400215 | Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer | active not recruiting | N/A | 190 | NYU Langone HealthOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT04303715 | No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonography | active not recruiting | N/A | 1,734 | Seoul National University HospitalOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT05892068 | A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain | active not recruiting | Phase 2 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT02624973 | PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial(PETREMAC) | active not recruiting | Phase 2 | 200 | Haukeland University HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT05383196 | Onvansertib + Paclitaxel In TNBC | active not recruiting | Phase 1 / Phase 2 | 50 | Antonio Giordano, MDOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT01674140 | S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer(e3) | active not recruiting | Phase 3 | 1,939 | SWOG Cancer Research NetworkNETWORK | 2 | Feb 10, 2026 | clinicaltrials |
| NCT05501886 | Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)(VIKTORIA-1) | active not recruiting | Phase 3 | 701 | Celcuity IncINDUSTRY | 23 | Feb 10, 2026 | clinicaltrials |
| NCT05909397 | Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer(VERITAC-3) | active not recruiting | Phase 3 | 59 | PfizerINDUSTRY | 10 | Feb 10, 2026 | clinicaltrials |
| NCT02308085 | Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer(POSITIVE) | active not recruiting | N/A | 518 | ETOP IBCSG Partners FoundationNETWORK | 22 | Feb 9, 2026 | clinicaltrials |
| NCT04478279 | A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors | active not recruiting | Phase 1 / Phase 2 | 125 | Sapience TherapeuticsINDUSTRY | 2 | Feb 9, 2026 | clinicaltrials |
| NCT04639986 | Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC) | active not recruiting | Phase 3 | 331 | Gilead SciencesINDUSTRY | 3 | Feb 9, 2026 | clinicaltrials |
| NCT05239143 | P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors | active not recruiting | Phase 1 | 180 | Poseida Therapeutics, Inc.INDUSTRY | 1 | Feb 9, 2026 | clinicaltrials |
| NCT05333874 | CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage | active not recruiting | Early Phase 1 | 34 | Rutgers, The State University of New JerseyOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT02747004 | A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer(Next MONARCH 1) | active not recruiting | Phase 2 | 234 | Eli Lilly and CompanyINDUSTRY | 14 | Feb 6, 2026 | clinicaltrials |
| NCT04909125 | Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation | active not recruiting | N/A | 132 | Royal North Shore HospitalOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT06175390 | Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer(SKYLINE) | active not recruiting | Phase 2 | 81 | Institut CurieOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT00907868 | Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS)(BONBIS) | active not recruiting | N/A | 2,004 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT02763566 | A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer(MONARCH plus) | active not recruiting | Phase 3 | 463 | Eli Lilly and CompanyINDUSTRY | 4 | Feb 5, 2026 | clinicaltrials |
| NCT05036096 | Cone Beam Breast CT for Breast Cancer Screening | active not recruiting | N/A | 1,024 | Koning CorporationINDUSTRY | 1 | Feb 5, 2026 | clinicaltrials |
| NCT01310530 | Partial Breast Proton Therapy for Early Stage Breast Cancer | active not recruiting | N/A | 150 | Loma Linda UniversityOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT03424915 | Exercise, Fitness and Tumor Profiling in Breast Cancer Patients | active not recruiting | — | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT03808662 | Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung | active not recruiting | Phase 2 | 107 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Feb 4, 2026 | clinicaltrials |
| NCT01468246 | The Young Women's Breast Cancer Study(HOHO) | active not recruiting | — | 1,302 | Dana-Farber Cancer InstituteOTHER | 2 | Feb 3, 2026 | clinicaltrials |
| NCT02246621 | A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer(MONARCH 3) | active not recruiting | Phase 3 | 493 | Eli Lilly and CompanyINDUSTRY | 22 | Feb 3, 2026 | clinicaltrials |
| NCT03070236 | PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions | active not recruiting | N/A | 912 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT04623554 | Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer(Neo-train) | active not recruiting | N/A | 102 | Zealand University HospitalOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT02297672 | Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant(PBSI) | active not recruiting | N/A | 75 | British Columbia Cancer AgencyOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT04454437 | Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments | active not recruiting | Phase 2 | 80 | Gilead SciencesINDUSTRY | 1 | Feb 2, 2026 | clinicaltrials |
| NCT05054010 | Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants | active not recruiting | — | 84 | Tethis S.p.A.INDUSTRY | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07068347 | Comparison Of VR & CPT, With And Without Lifestyle Modification, On ULD In Breast Cancer Survivors | active not recruiting | N/A | 60 | Superior UniversityOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT03615599 | Plant-based Diets and Risk of Cancer in the Adventist Health Study-2(AHS-2) | active not recruiting | — | 96,000 | Loma Linda UniversityOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT05130840 | Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer | active not recruiting | N/A | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT01984138 | REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy(REVIVE) | active not recruiting | Phase 2 | 33 | Polly A. Niravath, MDOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT01992432 | Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)(Brain fMRI-BC) | active not recruiting | — | 49 | City of Hope Medical CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT02432963 | Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy | active not recruiting | Phase 1 | 11 | City of Hope Medical CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT03984695 | Sexual Health Empowerment for Women's Health(SHE-WOMEN) | active not recruiting | N/A | 279 | University of Kansas Medical CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT06533670 | TME Alteration in HER2 Positive Breast Cancer | active not recruiting | — | 30 | Seoul National University HospitalOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT07371910 | Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer | active not recruiting | Phase 3 | 200 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT05968144 | Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness(ADRIAN) | active not recruiting | Phase 1 / Phase 2 | 30 | University of Maryland, BaltimoreOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT02057133 | A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread | active not recruiting | Phase 1 | 198 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2026 | clinicaltrials |
| NCT02492607 | Management of Low-risk (Grade I and II) DCIS(LORD) | active not recruiting | N/A | 2,500 | The Netherlands Cancer InstituteOTHER | 1 | Jan 26, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Feb 19, 2026source: clinicaltrials